All In Biotech

Free tool

FAERS Monitor: Rykindo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212849 or its brand name (Rykindo, Risperidone). Reports on generic versions are filed under their own applications.

Reports

62,767

Serious

49,125

78% of reports

Hospitalization

23,613

Death reported

5,853

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • gynaecomastia9,327
  • off label use5,623
  • drug ineffective5,251
  • weight increased4,374
  • drug interaction3,244
  • product use in unapproved indication2,945
  • emotional disorder2,875
  • abnormal weight gain2,863
  • condition aggravated2,364
  • somnolence2,303
  • toxicity to various agents2,292
  • extrapyramidal disorder2,076
  • emotional distress1,957
  • suicide attempt1,889
  • anxiety1,829

Reports by year received

View as table
YearReports
2004400
2005506
2006592
2007580
2008698
20091,200
20101,157
20111,587
20121,884
20131,528
20141,923
20154,815
20164,930
20176,885
20184,496
20194,735
20204,062
20213,694
20223,744
20233,471
20243,566
20253,578
20262,735

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,991,392 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
gynaecomastiaSignal9,327144.1140.9927,739
abnormal weight gainSignal2,863100.896.7217,369
emotional disorderSignal2,87534.433.184,548
extrapyramidal disorderSignal2,07630.529.254,277
suicide attemptSignal1,88910.710.316,209
drug interactionSignal3,2447.06.716,380
weight increasedSignal4,3746.76.520,826
emotional distressSignal1,9575.55.37,105
toxicity to various agentsSignal2,2924.64.46,425
product use in unapproved indicationSignal2,9454.03.96,671
somnolenceSignal2,3033.93.74,880
condition aggravatedSignal2,3642.62.52,378
anxietySignal1,8292.22.11,148
off label useSignal5,6232.22.13,627
drug ineffective5,2511.31.3472

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.